Valuation: LataMed AI Corp.

Market Cap 138M 119M 111M 101M 191M 13.15B 193M 1.31B 512M 6.59B 516M 505M 21.91B P/E 2024
-3.63x
P/E 2025 -102x
Enterprise Value 138M 119M 112M 102M 191M 13.19B 194M 1.31B 513M 6.61B 518M 507M 21.98B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
19.29%
Yield 2024 *
-
Yield 2025 -
08-11 LataMed AI Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-03 LataMed AI Corp. And DROGUERIAS LALA C.A. Enter Agreement To Develop AI And Automation Tools For Pharmaceutical And Laboratory Workflows CI
07-31 LataMed AI Corp. And Venezuelan Institute For Scientific Research Enter Agreement To Develop Digital Platform Supporting Access To IVIC Laboratory Services CI
07-28 LataMed AI Corp. Announces Through its Venezuelan Operating Subsidiary Enters Agreements with Colegio Claret and Colegio Roraima to Develop School-Based Digital Healthcare Initiatives CI
07-23 LataMed AI Corp. through its subsidiary LATAMEDAI VE, and FARMASER Enter Memorandum of Understanding to Develop Automation Platform for Pharmacy Operations CI
07-20 LataMed AI Corp Advances Industrial Telemedicine Initiative For Remote And Offshore Operations In Venezuela CI
07-06 LataMed AI Corp. Begins Planned Expansion into Colombia Through Initial Due Diligence and Strategic Planning CI
07-01 Latamed Ai Ve Executes Strategic Commercial Alliance with Cantv to Expand Digital Healthcare Services Across Venezuela CI
06-30 Latamed Ai Corp. and Vértice Seguros C.A. Execute Strategic Commercial Alliance to Expand Digital Healthcare and Insurance Ecosystem CI
06-24 LataMed AI Corp. And Focus Fitness C.A. Execute Strategic Commercial And Services Agreement CI
06-11 LataMed AI Corp Initiates Strategic Process to Evaluate Installment-Based Healthcare Payment Integration with Cashea Platform CI
05-26 LataMed AI Corp. Announces AI-Powered Pharmacy Fulfillment Initiative With Venezuelan Pharmacy Operators CI
05-20 LataMed AI Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
1 day+1.64%
1 week-17.54%
Current month-16.64%
1 month-60.32%
3 months-3.12%
6 months+280.37%
Current year+281.48%
1 week 0.46
Extreme 0.46235
2.49
1 month 0.19
Extreme 0.1854
2.49
Current year 0.1
Extreme 0.101663
2.49
1 year 0.07
Extreme 0.07311
2.49
3 years 0.05
Extreme 0.053
135
5 years 0.05
Extreme 0.053
135
10 years 0.05
Extreme 0.053
135
Manager TitleAgeSince
Chief Executive Officer 31 2026-02-16
Director of Finance/CFO 38 2026-03-30
Director TitleAgeSince
Director/Board Member 31 2026-02-16
Change 5-day change 1-year change 3-year change Capi.($)
+1.64%-17.54%+504.88%-95.48% 138M
-0.30%-0.20%+59.78%+105.99% 976M
-0.18%+1.09%-9.02%+0.36% 438M
-4.84%-9.23%-26.62%-80.50% 387M
+2.86%+4.73%-4.11%+30.17% 252M
+2.13%+22.71%+1,047.26%+1,295.83% 154M
0.00%-2.83%-13.60%+0.59% 60.6M
Average +0.17%+0.16%+222.65%+179.56% 343.63M
Weighted average by Cap. -0.42%-0.38%+113.36%+110.65%

Financials

2024 2025
Net sales - -
Net income -3.26M -2.82M -2.64M -2.41M -4.52M -312M -4.59M -30.96M -12.13M -156M -12.24M -11.98M -520M -207K -179K -168K -153K -288K -19.84M -292K -1.97M -772K -9.94M -779K -762K -33.06M
Net Debt 339K 293K 275K 250K 471K 32.45M 477K 3.22M 1.26M 16.26M 1.27M 1.25M 54.07M 395K 341K 320K 291K 548K 37.76M 555K 3.75M 1.47M 18.92M 1.48M 1.45M 62.93M
Logo LataMed AI Corp.
LataMed AI Corp., formerly Catalyst Crew Technologies Corp. is a Venezuela-based company primarily active in the Healthcare Technology sector. The Company is digital health and artificial intelligence technology enterprise, focusing on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled healthcare solutions for emerging markets. Such technologies are designed d to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven healthcare operations, with an initial regional focus on Latin American markets. The Company owns intellectual property assets relating to its artificial intelligence-enabled healthcare analytics platform, including issued patents and proprietary software, while the modules are in development.
Employees
3
Date Price Change Volume
26-08-17 US$0.4900 -12.62% 453,901
26-08-14 US$0.5608 -8.07% 59,662
26-08-13 US$0.6100 -4.69% 22,275
26-08-12 US$0.6400 -3.03% 45,038
26-08-11 US$0.6600 +9.73% 205,362
  1. Stock Market
  2. Stocks
  3. LMED Stock